Canonical ID: NK-fFZJQzy8wtbzJexRMrT4bA · Entity type: Company (reference)
| Property | Value | Lang | Source dataset | Source ID | First seen | ||
|---|---|---|---|---|---|---|---|
Company:country | us | eng | us_ne_med_exclusions | us-medne-fc3eabbf4a0e2bd9f842ac5411d2eb43b296cf47 | |||
Company:id | d2f6471bbca8d42cc0ef024a85b11a8f639ce2d0 | eng | us_ne_med_exclusions | us-medne-fc3eabbf4a0e2bd9f842ac5411d2eb43b296cf47 | |||
Company:name | Alcala Pharmaceutical, Inc. | eng | us_ne_med_exclusions | us-medne-fc3eabbf4a0e2bd9f842ac5411d2eb43b296cf47 | |||
Company:npiCode | 1255656153 | eng | us_ne_med_exclusions | us-medne-fc3eabbf4a0e2bd9f842ac5411d2eb43b296cf47 | |||
Company:sector | 16-Laboratory (Lab) (Independent) | eng | us_ne_med_exclusions | us-medne-fc3eabbf4a0e2bd9f842ac5411d2eb43b296cf47 | |||
Company:topics | debarment | eng | us_ne_med_exclusions | us-medne-fc3eabbf4a0e2bd9f842ac5411d2eb43b296cf47 | |||